
Scott Long
Examiner (ID: 7374, Phone: (571)272-9048 , Office: P/1633 )
| Most Active Art Unit | 1633 |
| Art Unit(s) | 1633 |
| Total Applications | 882 |
| Issued Applications | 557 |
| Pending Applications | 29 |
| Abandoned Applications | 301 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5247286
[patent_doc_number] => 20070243520
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-18
[patent_title] => 'Method for screening an agent for preventing or ameliorating wrinkles'
[patent_app_type] => utility
[patent_app_number] => 11/405471
[patent_app_country] => US
[patent_app_date] => 2006-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5035
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0243/20070243520.pdf
[firstpage_image] =>[orig_patent_app_number] => 11405471
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/405471 | Method for screening an agent for preventing or ameliorating wrinkles | Apr 17, 2006 | Issued |
Array
(
[id] => 5252805
[patent_doc_number] => 20070134261
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-06-14
[patent_title] => 'Effectors of innate immunity'
[patent_app_type] => utility
[patent_app_number] => 11/400411
[patent_app_country] => US
[patent_app_date] => 2006-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 117567
[patent_no_of_claims] => 85
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0134/20070134261.pdf
[firstpage_image] =>[orig_patent_app_number] => 11400411
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/400411 | Effectors of innate immunity | Apr 6, 2006 | Abandoned |
Array
(
[id] => 5687718
[patent_doc_number] => 20060286033
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-21
[patent_title] => 'Targeting pulmonary epithelium using ADRP'
[patent_app_type] => utility
[patent_app_number] => 11/397320
[patent_app_country] => US
[patent_app_date] => 2006-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 17502
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20060286033.pdf
[firstpage_image] =>[orig_patent_app_number] => 11397320
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/397320 | Targeting pulmonary epithelium using ADRP | Apr 2, 2006 | Issued |
Array
(
[id] => 5851719
[patent_doc_number] => 20060234910
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-10-19
[patent_title] => 'Methods for the treatment of insulin resistance and disease states characterized by insulin resistance'
[patent_app_type] => utility
[patent_app_number] => 11/388155
[patent_app_country] => US
[patent_app_date] => 2006-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10533
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20060234910.pdf
[firstpage_image] =>[orig_patent_app_number] => 11388155
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/388155 | Methods for the treatment of insulin resistance and disease states characterized by insulin resistance | Mar 22, 2006 | Abandoned |
Array
(
[id] => 5278627
[patent_doc_number] => 20090130759
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-05-21
[patent_title] => 'Culture Medium Containing Kinase Inhibitor, and Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 11/909545
[patent_app_country] => US
[patent_app_date] => 2006-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4329
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20090130759.pdf
[firstpage_image] =>[orig_patent_app_number] => 11909545
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/909545 | Culture Medium Containing Kinase Inhibitor, and Use Thereof | Mar 21, 2006 | Abandoned |
Array
(
[id] => 5888678
[patent_doc_number] => 20060275797
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-07
[patent_title] => 'Use of agents which inhibit connective tissue growth factor (CTGF) binding and signaling via the TrkA/p75NTR receptor complex for the prevention and treatment of CTGF-mediated ocular disorders'
[patent_app_type] => utility
[patent_app_number] => 11/384638
[patent_app_country] => US
[patent_app_date] => 2006-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5492
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20060275797.pdf
[firstpage_image] =>[orig_patent_app_number] => 11384638
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/384638 | Use of agents which inhibit connective tissue growth factor (CTGF) binding and signaling via the TrkA/p75NTR receptor complex for the prevention and treatment of CTGF-mediated ocular disorders | Mar 19, 2006 | Abandoned |
Array
(
[id] => 5759599
[patent_doc_number] => 20060210544
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-21
[patent_title] => 'Internally administered therapeutic agents for cranial nerve diseases comprising mesenchymal cells as an active ingredient'
[patent_app_type] => utility
[patent_app_number] => 11/377610
[patent_app_country] => US
[patent_app_date] => 2006-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 69
[patent_figures_cnt] => 69
[patent_no_of_words] => 38026
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0210/20060210544.pdf
[firstpage_image] =>[orig_patent_app_number] => 11377610
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/377610 | Internally administered therapeutic agents for cranial nerve diseases comprising mesenchymal cells as an active ingredient | Mar 16, 2006 | Abandoned |
Array
(
[id] => 4979384
[patent_doc_number] => 20070220619
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-20
[patent_title] => 'Methods for testing for caloric restriction (CR) mimetics'
[patent_app_type] => utility
[patent_app_number] => 11/377986
[patent_app_country] => US
[patent_app_date] => 2006-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 5367
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20070220619.pdf
[firstpage_image] =>[orig_patent_app_number] => 11377986
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/377986 | Methods for testing for caloric restriction (CR) mimetics | Mar 16, 2006 | Issued |
Array
(
[id] => 62963
[patent_doc_number] => 07758855
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-07-20
[patent_title] => 'DNA promoters and anthrax vaccines'
[patent_app_type] => utility
[patent_app_number] => 11/378003
[patent_app_country] => US
[patent_app_date] => 2006-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 50
[patent_no_of_words] => 12951
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/758/07758855.pdf
[firstpage_image] =>[orig_patent_app_number] => 11378003
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/378003 | DNA promoters and anthrax vaccines | Mar 16, 2006 | Issued |
Array
(
[id] => 5760144
[patent_doc_number] => 20060211089
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-21
[patent_title] => 'Expression of defensins in filamentous fungi'
[patent_app_type] => utility
[patent_app_number] => 11/377883
[patent_app_country] => US
[patent_app_date] => 2006-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13033
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0211/20060211089.pdf
[firstpage_image] =>[orig_patent_app_number] => 11377883
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/377883 | Expression of defensins in filamentous fungi | Mar 14, 2006 | Abandoned |
Array
(
[id] => 5148805
[patent_doc_number] => 20070048865
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-03-01
[patent_title] => 'Method for acceleration of stem cell differentiation'
[patent_app_type] => utility
[patent_app_number] => 11/377847
[patent_app_country] => US
[patent_app_date] => 2006-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2747
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20070048865.pdf
[firstpage_image] =>[orig_patent_app_number] => 11377847
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/377847 | Method for acceleration of stem cell differentiation | Mar 14, 2006 | Abandoned |
Array
(
[id] => 5135980
[patent_doc_number] => 20070077609
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-04-05
[patent_title] => 'Bioluminescence resonance energy transfer (BRET) systems and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/373679
[patent_app_country] => US
[patent_app_date] => 2006-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 26915
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20070077609.pdf
[firstpage_image] =>[orig_patent_app_number] => 11373679
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/373679 | Bioluminescence resonance energy transfer (BRET) systems and methods of use thereof | Mar 9, 2006 | Issued |
Array
(
[id] => 5734872
[patent_doc_number] => 20060259989
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-16
[patent_title] => 'Sporadic tumor mouse model for drug discovery'
[patent_app_type] => utility
[patent_app_number] => 11/371825
[patent_app_country] => US
[patent_app_date] => 2006-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6605
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0259/20060259989.pdf
[firstpage_image] =>[orig_patent_app_number] => 11371825
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/371825 | Sporadic tumor mouse model for drug discovery | Mar 8, 2006 | Abandoned |
Array
(
[id] => 5610523
[patent_doc_number] => 20060272039
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-11-30
[patent_title] => 'Methods of identifying longevity modulators and therapeutic methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/372469
[patent_app_country] => US
[patent_app_date] => 2006-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 26076
[patent_no_of_claims] => 62
[patent_no_of_ind_claims] => 32
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0272/20060272039.pdf
[firstpage_image] =>[orig_patent_app_number] => 11372469
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/372469 | Methods of identifying longevity modulators and therapeutic methods of use thereof | Mar 7, 2006 | Issued |
Array
(
[id] => 5699592
[patent_doc_number] => 20060216276
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-28
[patent_title] => 'Use of materials for treatment of central nervous system lesions'
[patent_app_type] => utility
[patent_app_number] => 11/368919
[patent_app_country] => US
[patent_app_date] => 2006-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 21757
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0216/20060216276.pdf
[firstpage_image] =>[orig_patent_app_number] => 11368919
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/368919 | Use of materials for treatment of central nervous system lesions | Mar 5, 2006 | Abandoned |
Array
(
[id] => 5786576
[patent_doc_number] => 20060205704
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-14
[patent_title] => 'Modulation of neurodegenerative diseases through the progesterone receptor'
[patent_app_type] => utility
[patent_app_number] => 11/365962
[patent_app_country] => US
[patent_app_date] => 2006-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 10142
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0205/20060205704.pdf
[firstpage_image] =>[orig_patent_app_number] => 11365962
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/365962 | Modulation of neurodegenerative diseases through the progesterone receptor | Feb 28, 2006 | Abandoned |
Array
(
[id] => 7795368
[patent_doc_number] => 08124074
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-02-28
[patent_title] => 'Fusion proteins'
[patent_app_type] => utility
[patent_app_number] => 11/792076
[patent_app_country] => US
[patent_app_date] => 2005-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 12516
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/124/08124074.pdf
[firstpage_image] =>[orig_patent_app_number] => 11792076
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/792076 | Fusion proteins | Nov 30, 2005 | Issued |
Array
(
[id] => 5866238
[patent_doc_number] => 20060100369
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-11
[patent_title] => 'Bifunctional-modified hydrogels'
[patent_app_type] => utility
[patent_app_number] => 11/273393
[patent_app_country] => US
[patent_app_date] => 2005-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 19635
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0100/20060100369.pdf
[firstpage_image] =>[orig_patent_app_number] => 11273393
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/273393 | Bifunctional-modified hydrogels | Nov 13, 2005 | Abandoned |
Array
(
[id] => 4886901
[patent_doc_number] => 20080261233
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-23
[patent_title] => 'Assessment of Biological Activity of Hepatocyte Growth Factor (Hgf)'
[patent_app_type] => utility
[patent_app_number] => 11/665893
[patent_app_country] => US
[patent_app_date] => 2005-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 5943
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0261/20080261233.pdf
[firstpage_image] =>[orig_patent_app_number] => 11665893
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/665893 | Assessment of Biological Activity of Hepatocyte Growth Factor (Hgf) | Oct 19, 2005 | Abandoned |
Array
(
[id] => 5917839
[patent_doc_number] => 20060130161
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-15
[patent_title] => 'Animal model systems for viral pathogenesis of neurodegeneration, autoimmune demyelination, and diabetes'
[patent_app_type] => utility
[patent_app_number] => 11/248499
[patent_app_country] => US
[patent_app_date] => 2005-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 23234
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20060130161.pdf
[firstpage_image] =>[orig_patent_app_number] => 11248499
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/248499 | Animal model systems for viral pathogenesis of neurodegeneration, autoimmune demyelination, and diabetes | Oct 11, 2005 | Abandoned |